Kurt M. Eichler, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 514 shares at $12.50 ($6K) on 2016-09-14, disclosed to the SEC on 2016-09-15.
Open-market purchase of $6k SBPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| SBPH | BUY | 2017-02-27 | $11K | — | Filing → |
| SBPH | BUY | 2016-11-10 | $61K | — | Filing → |
| SBPH | BUY | 2016-09-20 | $25K | — | Filing → |